811 related articles for article (PubMed ID: 26537358)
1. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
2. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
3. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
5. Mild mesangial proliferative IgA nephropathy with and without minimal change disease.
Wang S; Huang B; Wang P; Liu Y; Liu Y; Chen H; Zhang J
Clin Exp Med; 2023 Dec; 23(8):5367-5376. PubMed ID: 37796359
[TBL] [Abstract][Full Text] [Related]
6. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
7. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
9. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
[TBL] [Abstract][Full Text] [Related]
10. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study.
Wang J; Juan C; Huang Q; Zeng C; Liu Z
Nephrol Dial Transplant; 2013 Sep; 28(9):2339-45. PubMed ID: 23787555
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
13. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
Front Immunol; 2021; 12():700224. PubMed ID: 34456912
[TBL] [Abstract][Full Text] [Related]
14. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
Tan L; Tang Y; Peng W; Mathew BS; Qin W
Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.
Shen H; Gu W; Mao J; Zhu X; Jin X; Fu H; Liu A; Shu Q; Du L
Nephron; 2015; 130(1):21-8. PubMed ID: 25924689
[TBL] [Abstract][Full Text] [Related]
16. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
20. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
